Birdwatch Archive

Birdwatch Note

2024-08-01 15:43:24 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

The statement conflates concepts: Hyperandrogenism involves high androgen levels, not XY chromosomes. XY typically indicates male genetics, some intersex conditions (e.g., Androgen Insensitivity Syndrome) present female traits. https://rarediseases.info.nih.gov/diseases/5635/androgen-insensitivity-syndrome https://www.healthline.com/health/hyperandrogenism

Written by C1B33C87FC930AC1E491F3ECAEC3BBB37DAC6FAB4505D6DA2FE39F5D9E4F5149
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1819030524045754452

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1819036216001441810
  • noteId - 1819036216001441810
  • participantId -
  • noteAuthorParticipantId - C1B33C87FC930AC1E491F3ECAEC3BBB37DAC6FAB4505D6DA2FE39F5D9E4F5149 Participant Details
  • createdAtMillis - 1722527004608
  • tweetId - 1819030524045754452
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • The statement conflates concepts: Hyperandrogenism involves high androgen levels, not XY chromosomes. XY typically indicates male genetics, some intersex conditions (e.g., Androgen Insensitivity Syndrome) present female traits. https://rarediseases.info.nih.gov/diseases/5635/androgen-insensitivity-syndrome https://www.healthline.com/health/hyperandrogenism

Note Ratings

rated at rated by
2024-08-02 14:27:37 -0500 Rating Details
2024-08-02 13:03:30 -0500 Rating Details
2024-08-02 09:14:34 -0500 Rating Details
2024-08-02 08:47:07 -0500 Rating Details
2024-08-02 07:13:28 -0500 Rating Details
2024-08-02 06:29:45 -0500 Rating Details
2024-08-02 06:09:31 -0500 Rating Details
2024-08-02 05:04:16 -0500 Rating Details
2024-08-02 02:53:49 -0500 Rating Details
2024-08-02 02:30:00 -0500 Rating Details
2024-08-02 01:17:06 -0500 Rating Details
2024-08-02 00:59:48 -0500 Rating Details
2024-08-01 22:12:07 -0500 Rating Details
2024-08-01 20:43:50 -0500 Rating Details
2024-08-01 20:21:59 -0500 Rating Details
2024-08-01 18:27:59 -0500 Rating Details
2024-08-01 18:25:55 -0500 Rating Details
2024-08-01 18:07:17 -0500 Rating Details
2024-08-01 17:52:22 -0500 Rating Details
2024-08-01 17:18:35 -0500 Rating Details
2024-08-01 16:28:40 -0500 Rating Details
2024-08-01 16:25:36 -0500 Rating Details
2024-08-01 16:21:44 -0500 Rating Details
2024-08-01 16:18:07 -0500 Rating Details
2024-08-01 16:11:55 -0500 Rating Details
2024-08-01 15:55:37 -0500 Rating Details
2024-08-01 15:48:15 -0500 Rating Details
2024-08-01 15:41:58 -0500 Rating Details
2024-08-01 15:34:45 -0500 Rating Details
2024-08-01 15:26:08 -0500 Rating Details
2024-08-01 15:23:35 -0500 Rating Details
2024-08-01 15:22:44 -0500 Rating Details
2024-08-01 15:22:05 -0500 Rating Details
2024-08-01 15:20:39 -0500 Rating Details
2024-08-01 15:10:37 -0500 Rating Details
2024-08-01 15:09:02 -0500 Rating Details
2024-08-01 15:06:00 -0500 Rating Details
2024-08-01 14:55:55 -0500 Rating Details
2024-08-01 14:50:06 -0500 Rating Details
2024-08-01 14:47:00 -0500 Rating Details
2024-08-01 14:42:38 -0500 Rating Details
2024-08-01 14:42:28 -0500 Rating Details
2024-08-01 14:40:28 -0500 Rating Details
2024-08-01 14:23:51 -0500 Rating Details
2024-08-01 14:09:30 -0500 Rating Details
2024-08-01 14:06:30 -0500 Rating Details
2024-08-01 14:03:59 -0500 Rating Details
2024-08-01 14:01:40 -0500 Rating Details
2024-08-01 13:59:17 -0500 Rating Details
2024-08-01 13:44:26 -0500 Rating Details
2024-08-01 13:39:24 -0500 Rating Details
2024-08-01 13:32:02 -0500 Rating Details
2024-08-01 13:31:41 -0500 Rating Details
2024-08-01 13:28:10 -0500 Rating Details
2024-08-01 13:28:06 -0500 Rating Details
2024-08-01 13:26:33 -0500 Rating Details
2024-08-01 13:18:44 -0500 Rating Details
2024-08-01 13:15:31 -0500 Rating Details
2024-08-01 13:09:21 -0500 Rating Details
2024-08-01 13:00:13 -0500 Rating Details
2024-08-01 12:54:36 -0500 Rating Details
2024-08-01 12:54:08 -0500 Rating Details
2024-08-01 12:50:50 -0500 Rating Details
2024-08-01 12:49:11 -0500 Rating Details
2024-08-01 12:47:44 -0500 Rating Details
2024-08-01 12:46:53 -0500 Rating Details
2024-08-01 12:39:50 -0500 Rating Details
2024-08-01 12:39:38 -0500 Rating Details
2024-08-01 12:35:13 -0500 Rating Details
2024-08-01 12:30:12 -0500 Rating Details
2024-08-01 12:20:04 -0500 Rating Details
2024-08-01 12:08:14 -0500 Rating Details
2024-08-01 12:06:42 -0500 Rating Details
2024-08-01 12:06:08 -0500 Rating Details
2024-08-01 12:02:27 -0500 Rating Details
2024-08-01 12:02:22 -0500 Rating Details
2024-08-01 11:58:03 -0500 Rating Details
2024-08-01 11:57:25 -0500 Rating Details
2024-08-01 11:54:32 -0500 Rating Details
2024-08-01 11:54:13 -0500 Rating Details
2024-08-01 11:53:58 -0500 Rating Details
2024-08-01 11:53:27 -0500 Rating Details
2024-08-01 11:53:20 -0500 Rating Details
2024-08-01 11:53:13 -0500 Rating Details
2024-08-01 11:53:12 -0500 Rating Details
2024-08-01 11:53:11 -0500 Rating Details
2024-08-01 11:52:09 -0500 Rating Details
2024-08-01 11:51:19 -0500 Rating Details
2024-08-01 11:49:24 -0500 Rating Details
2024-08-01 11:48:56 -0500 Rating Details
2024-08-01 11:48:51 -0500 Rating Details
2024-08-01 11:48:03 -0500 Rating Details
2024-08-01 11:47:33 -0500 Rating Details
2024-08-01 11:46:56 -0500 Rating Details
2024-08-01 11:44:19 -0500 Rating Details
2024-08-01 11:42:56 -0500 Rating Details
2024-08-01 11:41:17 -0500 Rating Details
2024-08-01 11:40:25 -0500 Rating Details
2024-08-01 11:39:19 -0500 Rating Details
2024-08-01 11:37:15 -0500 Rating Details
2024-08-01 11:34:51 -0500 Rating Details
2024-08-01 11:31:23 -0500 Rating Details
2024-08-01 11:28:06 -0500 Rating Details
2024-08-01 11:24:37 -0500 Rating Details
2024-08-01 11:22:59 -0500 Rating Details
2024-08-01 11:20:03 -0500 Rating Details
2024-08-01 11:17:50 -0500 Rating Details
2024-08-01 11:16:11 -0500 Rating Details
2024-08-01 11:13:30 -0500 Rating Details
2024-08-01 11:12:41 -0500 Rating Details
2024-08-01 11:12:24 -0500 Rating Details
2024-08-01 11:09:11 -0500 Rating Details
2024-08-01 11:07:54 -0500 Rating Details
2024-08-01 11:07:12 -0500 Rating Details
2024-08-01 11:05:52 -0500 Rating Details
2024-08-01 11:04:17 -0500 Rating Details
2024-08-01 11:02:08 -0500 Rating Details
2024-08-01 10:57:58 -0500 Rating Details
2024-08-01 10:55:21 -0500 Rating Details
2024-08-01 10:53:12 -0500 Rating Details
2024-08-01 10:52:22 -0500 Rating Details
2024-08-01 10:51:48 -0500 Rating Details
2024-08-01 10:50:31 -0500 Rating Details
2024-08-04 01:50:23 -0500 Rating Details
2024-08-03 05:46:04 -0500 Rating Details
2024-08-02 19:58:18 -0500 Rating Details
2024-08-02 11:03:44 -0500 Rating Details
2024-08-02 10:11:42 -0500 Rating Details
2024-08-02 00:48:10 -0500 Rating Details
2024-08-01 23:41:02 -0500 Rating Details
2024-08-01 19:16:24 -0500 Rating Details